Available online

WHITE PAPER : A GAME-CHANGING PRECLINICAL TESTING MODEL FOR SYNERGISTIC IMMUNO-ONCOLOGY DRUG CANDIDATES

A standardized in vivo plateform:

in ovo human tumor xenografts

 

 

This white paper reviews the current benefits of immuno-oncology therapeutic strategies over conventional treatments and highlights the main difficulty facing drug developers today: the high

combinatorial complexity of finding effective new therapies.

It also gives an in-depth view the benefits of our unique preclinical in vivo chick embryo model, with selected case studies and supporting data.

To download our Webinar please provide us with your contact details.

 

If you wish to leave us a short description of your interests, a representative will contact you within one business day.

 

Download now :

* Fields required

By checking this box, I accept the privacy policy of this site.Learn more